What is the current stock price of Kineta, Inc. (KA)?

As of the latest market data, Kineta, Inc. (KA) is trading at $0.57. The stock has seen a loss of -30.77% today.

Does Kineta, Inc. (KA) pay a dividend?

Based on current data, Kineta, Inc. does not have a confirmed active dividend policy.

What is the market cap of Kineta, Inc.?

The current market capitalization of Kineta, Inc. (KA) is approximately unavailable.

KA

Kineta, Inc.·Healthcare

0.57

30.771%(−0.26)

Market Closed

0.74

28.785%(+0.17)

After Hours

Last Updated: — ET

52W L: $0.3352W H: $5.39

Company Profile

Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2016-02-11

Beta

0.57

Websitekinetabio.com↗